CD8 DCs are considered the classic cross-presenting DC and, for a long time, have been assumed to be the only mouse DC population with the ability to cross-present cell-associated antigens to CD8+ T cells. CD8 DCs display more efficient phagocytic uptake of dead cells and loading of antigenic

peptides into MHC class I than many other DC populations. In addition, CD8 DCs are able to produce high levels of bioactive IL-12p70 that helps in their induction of Th1/Tc1 responses. Acalabrutinib solubility dmso However, their capacity to present antigens in MHC class II to CD4+ T cells under conditions of limiting antigen is relatively poor (reviewed in [52]). Our studies show that FLT3L treatment greatly expanded the recently described mcDC population, that potently primes both CD4+ and CD8+ T cell to cell-associated antigens [12,23]. Importantly, T cells primed to cell-associated antigens by mcDC displayed greater primary expansion and development into memory cells than those primed by other DC populations.

The superior T cell priming capacity of mcDC can be contributed to several mechanisms. mcDC store phagoytosed materials in non-acid organelles and use this as an antigen depot which allows for prolonged antigen presentation [24]. Increasing the length of antigenic stimulation has been shown to positively affect T cell expansion, acquisition of effector functions and memory development [53–56]. Secondly, the type I IFN production by mcDC upon Selleckchem BMN 673 uptake of apoptotic material is likely to provide an adjuvant effect in both an autocrine and paracrine Selleckchem Fludarabine fashion (manuscript in preparation). Moreover, our previous observations indicated that mice deficient in type I IFN sensing failed to induce protective CD8+ T cell responses when treated with autologous tumour vaccines [12,23]. Besides the production of type I IFN, the mcDCs capacity to prime strong CD4+ T cell responses to cell-associated antigens

is also instrumental in the induction of anti-tumour CD8+ T cell responses. We and others have shown that CD4+ T cell help during priming of CD8+ T cells is required for optimal CD8+ T cell activation, primary expansion, acquisition of effector function and the development of memory [42,57,58]. Supportively, increasing CD4+ T cell help through transfer of (transgenic) CD4+ T cells or preimmunization of mice enhances the induction of CD8+ T cell responses [59,60]. In addition, ample studies indicate that CD4+ T cell help plays a supporting role in the maintenance, reactivation and expansion of existing memory cells [61–63]. FLT3L was shown recently to increase a DC population that had the ability to cross-present cell-associated antigens to CD8+ T cells without the need to express CD8α[64].